Siddique SS, Suelves AM, Baheti U, Foster CS (2013 Jan-Feb) Glaucoma and uveitis. Surv Ophthalmol. 58(1):1–10. https://doi.org/10.1016/j.survophthal.2012.04.006
Neri P, Azuara-Blanco A, Forrester JV (2004) Incidence of glaucoma in patients with uveitis. J Glaucoma 13(6):461–465. https://doi.org/10.1097/01.ijg.0000146391.77618.d0
Merayo-Lloves J, Power WJ, Rodriguez A, Pedroza-Seres M, Foster CS (1999) Secondary glaucoma in patients with uveitis. Ophthalmologica 213(5):300–304. https://doi.org/10.1159/000027443
Takahashi T, Ohtani S, Miyata K, Miyata N, Shirato S, Mochizuki M (2002 Sep-Oct) A clinical evaluation of uveitis-associated secondary glaucoma. Jpn J Ophthalmol 46(5):556–562. https://doi.org/10.1016/s0021-5155(02)00549-x
Heinz C, Koch JM, Zurek-Imhoff B, Heiligenhaus A (2009) Prevalence of uveitic secondary glaucoma and success of nonsurgical treatment in adults and children in a tertiary referral center. Ocul Immunol Inflamm 17(4):243–248. https://doi.org/10.1080/09273940902913035
Dick AD, Tundia N, Sorg R, Zhao C, Chao J, Joshi A, Skup M (2016) Risk of Ocular Complications in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis. Ophthalmology. ;123(3):655 – 62. https://doi.org/10.1016/j.ophtha.2015.10.028. Epub 2015 Dec 19. Erratum in: Ophthalmology. 2016;123(11):2439. https://doi.org/10.1016/j.ophtha.2016.09.006.
Daniel E, Pistilli M, Kothari S, Khachatryan N, Kaçmaz RO, Gangaputra SS, Sen HN, Suhler EB, Thorne JE, Foster CS, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Bhatt NP, Kempen JH, Systemic Immunosuppressive Therapy for Eye Diseases Research Group (2017) Risk of ocular hypertension in adults with noninfectious uveitis. Ophthalmology 124(8):1196–1208. https://doi.org/10.1016/j.ophtha.2017.03.041Epub 2017 Apr 19
Niederer RL, Wong ABC, Ma T, Chew S, Sims J (2023) Predictors of glaucoma in patients with uveitis and scleritis. Eye (Lond) 37(6):1254–1257. https://doi.org/10.1038/s41433-022-02101-7Epub 2022 May 24
Ma T, Sims JL, Bennett S, Chew S, Niederer RL (2022) High rate of conversion from ocular hypertension to glaucoma in subjects with uveitis. Br J Ophthalmol 106(11):1520–1523. https://doi.org/10.1136/bjophthalmol-2021-318809Epub 2021 May 21
Liu X, Kelly SR, Montesano G, Bryan SR, Barry RJ, Keane PA, Denniston AK, Crabb DP (2019) Evaluating the impact of uveitis on visual field progression using Large-Scale Real-World data. Am J Ophthalmol 207:144–150 Epub 2019 Jun 26
Carreño E, Villarón S, Portero A, Herreras JM, Maquet JA, Calonge M (2011) Surgical outcomes of uveitic glaucoma. J Ophthalmic Inflamm Infect 1(2):43–53. https://doi.org/10.1007/s12348-010-0012-8Epub 2010 Nov 18
Halkiadakis I, Konstantopoulou K, Tzimis V, Papadopoulos N, Chatzistefanou K, Markomichelakis NN (2024) Update on diagnosis and treatment of uveitic glaucoma. J Clin Med 13(5):1185. https://doi.org/10.3390/jcm13051185
Almobarak FA, Alharbi AH, Morales J, Aljadaan I (2018) The influence of mitomycin C concentration on the outcome of trabeculectomy in uveitic glaucoma. Int Ophthalmol 38(6):2371–2379. https://doi.org/10.1007/s10792-017-0737-6Epub 2017 Oct 14
Iwao K, Inatani M, Seto T, Takihara Y, Ogata-Iwao M, Okinami S, Tanihara H (2014) Long-term outcomes and prognostic factors for trabeculectomy with mitomycin C in eyes with uveitic glaucoma: a retrospective cohort study. J Glaucoma 23(2):88–94. https://doi.org/10.1097/IJG.0b013e3182685167
Hoffmann EM, Hengerer F, Klabe K, Schargus M, Thieme H, Voykov B (2021) Aktuelle Glaukomchirurgie [Glaucoma surgery today]. Ophthalmologe. ;118(3):239–247. German. https://doi.org/10.1007/s00347-020-01146-x. Erratum in: Ophthalmologe. 2021;118(Suppl 2):183. https://doi.org/10.1007/s00347-021-01457-7.
Almobarak FA, Alharbi AH, Aljadaan I, Aldhibi H (2021) Long-term outcomes of initial trabeculectomy in glaucoma associated with granulomatous and non-granulomatous uveitis. Int Ophthalmol 41(10):3459–3470. https://doi.org/10.1007/s10792-021-01910-1Epub 2021 Jun 7
Bitossi A, Mattioli I, Bettiol A, Palermo A, Malandrino D, Bacherini D, Virgili G, Giansanti F, Vannozzi L, Silvestri E (2023) Non-anti TNFα biologic agents for noninfectious uveitis associated with systemic inflammatory diseases: a systematic review. Expert Rev Clin Immunol 19(5):549–560 Epub 2023 Mar 27
Sonoda KH, Hasegawa E, Namba K, Okada AA, Ohguro N, Goto H, JOIS (Japanese Ocular Inflammation Society) Uveitis Survey Working Group (2021) Epidemiology of uveitis in japan: a 2016 retrospective nationwide survey. Jpn J Ophthalmol 65(2):184–190. https://doi.org/10.1007/s10384-020-00809-1Epub 2021 Mar 11
Chauhan K, Tyagi M (2024) Update on non-infectious uveitis treatment: anti-TNF-alpha and beyond. Front Ophthalmol (Lausanne) 4:1412930. https://doi.org/10.3389/fopht.2024.1412930
Kalogeropoulos D, Sung VC, Curr Glaucoma J Pract (2018) Sep-Dec ;12(3):125–138. https://doi.org/10.5005/jp-journals-10028-1257
Pillai MR, Balasubramaniam N, Wala N, Mathews AM, Tejeswi B, Krishna H, Ishrath D, Rathinam SR, Sithiq Uduman SM (2024) Glaucoma in uveitic eyes: long-term clinical course and management measures. Ocul Immunol Inflamm 32(6):1041–1047 Epub 2023 May 4
Mosaed S (2020) Ab interno trabeculotomy in uveitic glaucoma: confirmation of original results with extended applications. Clin Exp Ophthalmol 48(1):12–13. https://doi.org/10.1111/ceo.13699
Ikegawa W, Suzuki T, Namiguchi K, Mizoue S, Shiraishi A, Ohashi Y (2016) Changes in anterior segment morphology of Iris Bombe before and after laser peripheral iridotomy in patients with uveitic secondary glaucoma. J Ophthalmol 2016:8496201. https://doi.org/10.1155/2016/8496201
Škrlová E, Svozílková P, Heissigerová J, Fichtl M (2023) Pathogenesis and current methods of treatment, of secondary uveitic glaucoma. a review. Cesk Slov Oftalmol 79(3):111–115 English. https://doi.org/10.31348/2023/7
Shrestha S, Thapa M, Shah DN (2014) Pattern of intraocular pressure fluctuation in uveitic eyes treated with corticosteroids. Ocul Immunol Inflamm 22(2):110–115. https://doi.org/10.3109/09273948.2013.824106
Razeghinejad MR, Katz LJ (2012) Steroid-induced iatrogenic glaucoma. Ophthalmic Res 47(2):66–80. https://doi.org/10.1159/000328630
Alaghband P, Baneke AJ, Galvis E, Madekurozwa M, Chu B, Stanford M, Overby D, Lim KS (2019) Aqueous humor dynamics in uveitic eyes. Am J Ophthalmol 208:347–355 Epub 2019 Aug 30
Yorio T, Patel GC, Clark AF (2020) Glucocorticoid-induced ocular hypertension: origins and new approaches to minimize. Expert Rev Ophthalmol 15(3):145–157 Epub 2020 May 14
Chang SM, St Peter DM, Im LT, Munir WM, Schocket LS (2022) Dexamethasone implant migration in an eye with congenital glaucoma: a case report and review of the literature. Eur J Ophthalmol 32(5):NP46–NP50. Epub 2021 Mar 29 https://doi.org/10.1177/11206721211005696
Nguyen QD, Merrill PT, Jaffe GJ, Dick AD, Kurup SK, Sheppard J, Schlaen A, Pavesio C, Cimino L, Van Calster J, Camez AA, Kwatra NV, Song AP, Kron M, Tari S, Brézin AP (2016) Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet. ;388(10050):1183-92. https://doi.org/10.1016/S0140-6736(16)31339-3. Epub 2016 Aug 16. Erratum in: Lancet. 2016;388(10050):1160. doi: 10.1016/S0140-6736(16)31538-0
Suhler EB, Adán A, Brézin AP, Fortin E, Goto H, Jaffe GJ, Kaburaki T, Kramer M, Lim LL, Muccioli C, Nguyen QD, Van Calster J, Cimino L, Kron M, Song AP, Liu J, Pathai S, Camez A, Schlaen A, van Velthoven MEJ, Vitale AT, Zierhut M, Tari S, Dick AD (2018) Safety and efficacy of adalimumab in patients with noninfectious uveitis in an ongoing Open-Label study: VISUAL III. Ophthalmology 125(7):1075–1087. https://doi.org/10.1016/j.ophtha.2017.12.039Epub 2018 Feb 9
Inoue T (2017) [The science of glaucoma surgery -Filtration surgery and the role of Cytokines]. Nippon Ganka Gakkai Zasshi 121(3):314–334 Japanese
Lee J, Choi JA, Ju HH, Kim JE, Paik SY, Rao PV (2021) Role of MCP-1 and IL-8 in viral anterior uveitis, and contractility and fibrogenic activity of trabecular meshwork cells. Sci Rep 11(1):14950. https://doi.org/10.1038/s41598-021-94391-2
Suzuki K, Iwata D, Namba K, Hase K, Hiraoka M, Murata M, Kitaichi N, Foxton R, Ishida S (2023) Involvement of angiopoietin 2 and vascular endothelial growth factor in uveitis. PLoS ONE 18(11):e0294745. https://doi.org/10.1371/journal.pone.0294745
Singh S, Anshita D, Ravichandiran V (2021) MCP-1: Function, regulation, and involvement in disease. Int Immunopharmacol. 101(Pt B):107598. https://doi.org/10.1016/j.intimp.2021.107598
